These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 2650276)

  • 1. The effect of HLA lymphocytotoxic antibody status and crossmatch result on cardiac transplant survival.
    McCloskey D; Festenstein H; Banner N; Hawes R; Holmes J; Khaghani A; Smith J; Yacoub M
    Transplant Proc; 1989 Feb; 21(1 Pt 1):804-6. PubMed ID: 2650276
    [No Abstract]   [Full Text] [Related]  

  • 2. The influence of HLA matching and lymphocytotoxic antibody status in heart-lung allograft recipients receiving cyclosporin and azathioprine.
    Festenstein H; Banner N; Smith J; Awad J; Burden M; Fitzgerald N; Holmes J; Khaghani A; Smith J; McCloskey D
    Transplant Proc; 1989 Feb; 21(1 Pt 1):797-8. PubMed ID: 2495632
    [No Abstract]   [Full Text] [Related]  

  • 3. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC; Ozawa M
    Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Excellent renal allograft survival in donor-specific antibody positive transplant patients-role of intravenous immunoglobulin and rabbit antithymocyte globulin.
    Mai ML; Ahsan N; Wadei HM; Genco PV; Geiger XJ; Willingham DL; Taner CB; Hewitt WR; Grewal HP; Nguyen JH; Hughes CB; Gonwa TA
    Transplantation; 2009 Jan; 87(2):227-32. PubMed ID: 19155977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction between panel reactive antibodies, auto- and cold reactive antibodies, and a positive B cell cross-match in renal and cardiac allograft survival.
    Creemers P; Brink J; Kahn D
    Clin Transplant; 1997 Apr; 11(2):134-8. PubMed ID: 9113450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical relevance of complement-fixing antibodies in cardiac transplantation.
    Rose ML; Smith JD
    Hum Immunol; 2009 Aug; 70(8):605-9. PubMed ID: 19375471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of HLA matching in heart transplantation. Collaborative Heart Transplant Study.
    Opelz G
    Transplant Proc; 1989 Feb; 21(1 Pt 1):794-6. PubMed ID: 2650297
    [No Abstract]   [Full Text] [Related]  

  • 8. Heart transplantation across antibodies against human leukocyte antigen and ABO-post-transplant follow-up of donor reactive antibodies.
    Bućin D; Johansson S; Lindberg LO
    Xenotransplantation; 2006 Mar; 13(2):101-4. PubMed ID: 16623800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-HLA antibodies and heart allograft survival.
    Fenoglio J; Ho E; Reed E; Rose E; Smith C; Reemstma K; Marboe C; Suciu-Foca N
    Transplant Proc; 1989 Feb; 21(1 Pt 1):807-9. PubMed ID: 2650277
    [No Abstract]   [Full Text] [Related]  

  • 10. Influence of donor-recipient lymphocyte crossmatch and ABO status on rejection risk in cardiac transplantation.
    McKenzie FN; Tadros N; Stiller C; Keown P; Sinclair N; Kostuk W
    Transplant Proc; 1987 Aug; 19(4):3439-41. PubMed ID: 3303513
    [No Abstract]   [Full Text] [Related]  

  • 11. HLA compatibility and organ transplant survival. Collaborative Transplant Study.
    Opelz G; Wujciak T; Döhler B; Scherer S; Mytilineos J
    Rev Immunogenet; 1999; 1(3):334-42. PubMed ID: 11256424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of post-transplant anti-HLA antibody measurements in pediatric cardiac transplant recipients.
    Xydas S; Yang JK; Burke EM; Chen JM; Addonizio LJ; Mital SR; Itescu S; Hsu DT; Lamour JM
    J Heart Lung Transplant; 2005 Sep; 24(9):1289-96. PubMed ID: 16143247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The feasibility of HLA matching for lung transplantation.
    McGee C; Fox MD; Loyd JE
    Clin Transplant; 1996 Dec; 10(6 Pt 1):564-7. PubMed ID: 8996780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corneal transplantation: a single center experience 1976 to 1988.
    Völker-Dieben HJ; D'Amaro J
    Clin Transpl; 1988; ():249-61. PubMed ID: 3154477
    [No Abstract]   [Full Text] [Related]  

  • 15. [HLA-compatibility testing in kidney transplantation--past, present and future].
    van Rood JJ; Persijn GG; van Leeuwen A; Goulmy E; Lansbergen Q; Cohen B
    Chirurg; 1980 May; 51(5):257-62. PubMed ID: 6447582
    [No Abstract]   [Full Text] [Related]  

  • 16. The clinical relevance of HLA matching in heart transplantation: impact on rejection and donor-directed cytotoxicity of graft infiltrating lymphocytes.
    Baan CC; Ouwehand AJ; Vaessen LM; Jutte NH; Balk AH; Mochtar B; Claas FH; Weimar W
    Transplant Proc; 1991 Oct; 23(5):2670-1. PubMed ID: 1926527
    [No Abstract]   [Full Text] [Related]  

  • 17. Successful transplantation after conversion of a positive crossmatch to negative by dissociation of IgM antibody.
    Louis P; Senitzer D; Tellis VA; Matas AJ
    Transplant Proc; 1989 Feb; 21(1 Pt 1):764-5. PubMed ID: 2650262
    [No Abstract]   [Full Text] [Related]  

  • 18. Improvement of graft prognosis in penetrating normal-risk keratoplasty by HLA class I and II matching.
    Reinhard T; Böhringer D; Enczmann J; Kögler G; Mayweg S; Wernet P; Sundmacher R
    Eye (Lond); 2004 Mar; 18(3):269-77. PubMed ID: 15004576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical relevance of antibodies to HLA antigens undetectable by the standard complement-dependent cytotoxicity test.
    Slavcev A; Lácha J; Honsová E; Sajdlová H; Lodererová A; Vítko S; Valhová S; Stríz I; Ivasková E
    Transpl Int; 2003 Dec; 16(12):872-8. PubMed ID: 12904845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of positive kidney, heart, and liver transplant crossmatches reported to the Collaborative Transplant Study.
    Opelz G; Döhler B; Süsal C
    Hum Immunol; 2009 Aug; 70(8):627-30. PubMed ID: 19375469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.